These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23242325)

  • 1. Irreversible leukoencephalopathy after reduced-intensity stem cell transplantation in a dyskeratosis congenita patient with TINF2 mutation.
    Isoda T; Mitsuiki N; Ohkawa T; Kaneko S; Endo A; Ono T; Aoki Y; Tomizawa D; Kajiwara M; Araki S; Nagasawa M; Morio T; Takagi M; Mizutani S
    J Pediatr Hematol Oncol; 2013 May; 35(4):e178-82. PubMed ID: 23242325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex.
    Sarper N; Zengin E; Kılıç SÇ
    Pediatr Blood Cancer; 2010 Dec; 55(6):1185-6. PubMed ID: 20979174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita.
    Nishio N; Takahashi Y; Ohashi H; Doisaki S; Muramatsu H; Hama A; Shimada A; Yagasaki H; Kojima S
    Pediatr Transplant; 2011 Mar; 15(2):161-6. PubMed ID: 21176016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal vasculopathy in autosomal dominant dyskeratosis congenita due to TINF2 mutation.
    Gleeson M; O'Marcaigh A; Cotter M; Brosnahan D; Vulliamy T; Smith OP
    Br J Haematol; 2012 Dec; 159(5):498. PubMed ID: 23094712
    [No Abstract]   [Full Text] [Related]  

  • 5. Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita.
    Bohn OL; Whitten J; Spitzer B; Kobos R; Prockop S; Boulad F; Arcila M; Wang L; Teruya-Feldstein J
    Int J Surg Pathol; 2013 Oct; 21(5):520-5. PubMed ID: 23222806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation.
    Fukuhara A; Tanino Y; Ishii T; Inokoshi Y; Saito K; Fukuhara N; Sato S; Saito J; Ishida T; Yamaguchi H; Munakata M
    Eur Respir J; 2013 Dec; 42(6):1757-9. PubMed ID: 24072216
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita.
    Elmahadi S; Muramatsu H; Kojima S
    Curr Opin Hematol; 2016 Nov; 23(6):501-507. PubMed ID: 27607446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of dyskeratosis congenita-associated pulmonary fibrosis with danazol.
    Zlateska B; Ciccolini A; Dror Y
    Pediatr Pulmonol; 2015 Dec; 50(12):E48-51. PubMed ID: 26083318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita.
    Du H; Guo Y; Ma D; Tang K; Cai D; Luo Y; Xie C
    Medicine (Baltimore); 2018 May; 97(19):e0724. PubMed ID: 29742735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dyskeratosis congenital: clinical features and genotype analysis in two Chinese patients].
    Liu R; Shi XD; Wang TY; Liu ZQ; Hu T; Fan W; Cao J; Hou R; Liang C; Huang SA
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):684-7. PubMed ID: 22339828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita.
    Dror Y; Freedman MH; Leaker M; Verbeek J; Armstrong CA; Saunders FE; Doyle JJ
    Bone Marrow Transplant; 2003 May; 31(10):847-50. PubMed ID: 12748659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood.
    Sasa GS; Ribes-Zamora A; Nelson ND; Bertuch AA
    Clin Genet; 2012 May; 81(5):470-8. PubMed ID: 21477109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.
    O'Connell N; Goodyer M; Gleeson M; Storey L; Williams M; Cotter M; O'Marcaigh A; Smith O
    Pediatr Transplant; 2014 Feb; 18(1):E22-4. PubMed ID: 24168326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.
    Savage SA; Giri N; Baerlocher GM; Orr N; Lansdorp PM; Alter BP
    Am J Hum Genet; 2008 Feb; 82(2):501-9. PubMed ID: 18252230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita.
    Savage SA; Giri N; Jessop L; Pike K; Plona T; Burdett L; Alter BP
    J Med Genet; 2011 Apr; 48(4):285-8. PubMed ID: 21209122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after Hematopoietic Stem Cell Transplant in Patients with Dyskeratosis Congenita: Systematic Review of the Literature.
    Barbaro P; Vedi A
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1152-1158. PubMed ID: 26968789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.
    Li F; Li W; Qiao X; Xie X
    Int J Hematol; 2019 Mar; 109(3):328-335. PubMed ID: 30604317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse hemorrhagic colitis in a patient with dyskeratosis congenita after nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Ehlert K; Rossig C; Groll AH; Beyna T; Froehlich B; Juergens H
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e41-4. PubMed ID: 25000468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone marrow failure due to telomere associated gene mutation].
    Yamaguchi H; Dan K
    Rinsho Ketsueki; 2010 Aug; 51(8):646-53. PubMed ID: 20805671
    [No Abstract]   [Full Text] [Related]  

  • 20. Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.
    Choo S; Lorbeer FK; Regalado SG; Short SB; Wu S; Rieser G; Bertuch AA; Hockemeyer D
    Blood; 2022 Aug; 140(6):608-618. PubMed ID: 35421215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.